A Highly Atom-Efficient Prodrug Approach to Generate Synergy between H 2 S and Nonsteroidal Anti-inflammatory Drugs and Improve Safety
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c01254 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Wen Peng und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Drug Discovery, China Pharma…. Hauptthemen laut MEDLINE: Prodrugs, Hydrogen Sulfide, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Efforts to synergize hydrogen sulfide (H2S) with NSAIDs have faced challenges due to complex structural entities and independent release kinetics. This study presents a highly atom-efficient approach of using a thiocarboxylic acid (thioacid) as a novel H2S releasing precursor and successfully employs it to modify NSAIDs, which offers several critical advantages. First, thioacid-modified NSAID is active in inhibiting cyclooxygenase, sometimes with improved potency. Second, this prodrug approach avoids introducing extra structural moieties, allowing for the release of only the intended active principals. Third, the release of H2S and NSAID is concomitant, thus optimally synchronizing the concentration profiles of the two active principals. The design is based on our discovery that esterases can directly and efficiently hydrolyze thiocarboxylic acids, enabling controlled release H2S. This study demonstrates the proof of principle through synthesizing analogs, assesses release kinetics, enzyme inhibition, and pharmacological efficacy, and evaluates toxicity and gut microbiota regulation in animal models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Drug Discovery, China Pharmaceutical University, Nanjing 211198, P. R. China.
- Department of Chemistry, China Pharmaceutical University, Nanjing 211198, P. R. China.
- Department of Cardiac Surgery Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California 90048, United States.
- Drug Discovery and Design Center, The Center for Chemical Biology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
- College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China.
- Department of Chemistry and Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, Georgia 30303, United States.
ORCID-Profile: Cheng Luo, Fei Ye, Weiwei Guo, Yueqin Zheng
Förderung
- Natural Science Foundation of Jiangsu Province
- National Natural Science Foundation of China
Zitieren
APA
Peng, W., Qin, L., Wang, T., Sun, Y., Li, Z., Lefer, D. J., Luo, C., Ye, F., Wang, B., Guo, W., & Zheng, Y. (2024). A Highly Atom-Efficient Prodrug Approach to Generate Synergy between H 2 S and Nonsteroidal Anti-inflammatory Drugs and Improve Safety. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01254
Vancouver
Peng W, Qin L, Wang T, Sun Y, Li Z, Lefer DJ, et al. A Highly Atom-Efficient Prodrug Approach to Generate Synergy between H 2 S and Nonsteroidal Anti-inflammatory Drugs and Improve Safety. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c01254
BibTeX
@article{Peng2024,
author = {Peng, Wen and Qin, Lixiao and Wang, Tianci and Sun, Yangqian and Li, Zhen and Lefer, David J and Luo, Cheng and Ye, Fei and Wang, Binghe and Guo, Weiwei and Zheng, Yueqin},
title = {A Highly Atom-Efficient Prodrug Approach to Generate Synergy between H 2 S and Nonsteroidal Anti-inflammatory Drugs and Improve Safety},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c01254}
}
EUVIMED